Literature DB >> 19258279

New combinations of mutations in VanD-Type vancomycin-resistant Enterococcus faecium, Enterococcus faecalis, and Enterococcus avium strains.

F Depardieu1, M-L Foucault, J Bell, A Dubouix, M Guibert, J-P Lavigne, M Levast, P Courvalin.   

Abstract

We studied the clinical isolates Enterococcus faecium NEF1, resistant to high levels of vancomycin (MIC, 512 microg/ml) and teicoplanin (MIC, 64 microg/ml); Enterococcus faecium BM4653 and BM4656 and Enterococcus avium BM4655, resistant to moderate levels of vancomycin (MIC, 32 microg/ml) and to low levels of teicoplanin (MIC, 4 microg/ml); and Enterococcus faecalis BM4654, moderately resistant to vancomycin (MIC, 16 microg/ml) but susceptible to teicoplanin (MIC, 0.5 microg/ml). The strains were distinct, were constitutively resistant via the synthesis of peptidoglycan precursors ending in D-alanyl-D-lactate, and harbored a chromosomal vanD gene cluster that was not transferable. New mutations were found in conserved domains of VanS(D): at T(170)I near the phosphorylation site in NEF1, at V(67)A at the membrane surface in BM4653, at G(340)S in the G2 ATP-binding domain in BM4655, in the F domain in BM4656 (a 6-bp insertion), and in the G1 and G2 domains of BM4654 (three mutations). The mutations resulted in constitutivity, presumably through the loss of the phosphatase activity of the sensor. The chromosomal Ddl D-Ala:D-Ala ligase had an IS19 copy in NEF1, a mutation in the serine (S(185)F) or near the arginine (T(289)P) involved in D-Ala1 binding in BM4653 or BM4655, respectively, and a mutation next to the lysine (P(180)S) involved in D-Ala2 binding in BM4654, leading to the production of an impaired enzyme. In BM4653 vanY(D), a new insertion sequence, ISEfa9, belonging to the IS3 family, resulted in the absence of D,D-carboxypeptidase activity. Strain BM4656 had a functional D-Ala:D-Ala ligase, associated with high levels of both VanX(D) and VanY(D) activities, and is the first example of a VanD-type strain with a functional Ddl enzyme. Study of these five clinical isolates, displaying various assortments of mutations, confirms that all VanD-type strains isolated so far have undergone mutations in the vanS(D) or vanR(D) gene, leading to constitutive resistance, but that the Ddl host ligase is not always impaired. Based on sequence differences, the vanD gene clusters could be assigned to two subtypes: vanD-1 and vanD-4.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19258279      PMCID: PMC2681503          DOI: 10.1128/AAC.01348-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  38 in total

1.  Molecular characterization of the vanD gene cluster and a novel insertion element in a vancomycin-resistant enterococcus isolated in Canada.

Authors:  D A Boyd; J Conly; H Dedier; G Peters; L Robertson; E Slater; M R Mulvey
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  The role of the G2 box, a conserved motif in the histidine kinase superfamily, in modulating the function of EnvZ.

Authors:  Yan Zhu; Masayori Inouye
Journal:  Mol Microbiol       Date:  2002-08       Impact factor: 3.501

3.  An inocula replicating apparatus for routine testing of bacterial susceptibility to antibiotics.

Authors:  E STEERS; E L FOLTZ; B S GRAVES
Journal:  Antibiot Chemother (Northfield)       Date:  1959-05

Review 4.  Modes and modulations of antibiotic resistance gene expression.

Authors:  Florence Depardieu; Isabelle Podglajen; Roland Leclercq; Ekkehard Collatz; Patrice Courvalin
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

5.  Glycopeptide-resistant Enterococcus faecium BM4416 is a VanD-type strain with an impaired D-Alanine:D-Alanine ligase.

Authors:  B Perichon; B Casadewall; P Reynolds; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

6.  Influence of transferable genetic determinants on the outcome of typing methods commonly used for Enterococcus faecium.

Authors:  Guido Werner; Rob J L Willems; Bianca Hildebrandt; Ingo Klare; Wolfgang Witte
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

7.  First infection with VanD-type glycopeptide-resistant Enterococcus faecium in Europe.

Authors:  Jean-Philippe Lavigne; Hélène Marchandin; Nicole Bouziges; Albert Sotto
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

8.  Enterococcus gallinarum N04-0414 harbors a VanD-type vancomycin resistance operon and does not contain a D-alanine:D-alanine 2 (ddl2) gene.

Authors:  David A Boyd; Mark A Miller; Michael R Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

Review 9.  VanD-type vancomycin-resistant Enterococcus faecium 10/96A.

Authors:  Florence Depardieu; Peter E Reynolds; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

10.  vanD and vanG-like gene clusters in a Ruminococcus species isolated from human bowel flora.

Authors:  M-C Domingo; A Huletsky; R Giroux; F J Picard; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

View more
  7 in total

1.  Identification of a Novel Genomic Island Associated with vanD-Type Vancomycin Resistance in Six Dutch Vancomycin-Resistant Enterococcus faecium Isolates.

Authors:  Janetta Top; Jan C Sinnige; Ellen C Brouwer; Guido Werner; Jukka Corander; Juliëtte A Severin; Rogier Jansen; E Bathoorn; Marc J M Bonten; John W A Rossen; Rob J L Willems
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

2.  Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.

Authors:  Sébastien Coyne; Ghislaine Guigon; Patrice Courvalin; Bruno Périchon
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

3.  Transferable vancomycin resistance in clade B commensal-type Enterococcus faecium.

Authors:  François Lebreton; Michael D Valentino; Katharina Schaufler; Ashlee M Earl; Vincent Cattoir; Michael S Gilmore
Journal:  J Antimicrob Chemother       Date:  2018-06-01       Impact factor: 5.790

4.  Ribaxamase, an Orally Administered β-Lactamase, Diminishes Changes to Acquired Antimicrobial Resistance of the Gut Resistome in Patients Treated with Ceftriaxone.

Authors:  John F Kokai-Kun; Chenxiong Le; Kenneth Trout; Julia L Cope; Nadim J Ajami; Andrew J Degar; Sheila Connelly
Journal:  Infect Drug Resist       Date:  2020-07-22       Impact factor: 4.003

5.  Vancomycin does not affect the enzymatic activities of purified VanSA.

Authors:  Elizabeth C Upton; Lina J Maciunas; Patrick J Loll
Journal:  PLoS One       Date:  2019-01-24       Impact factor: 3.240

6.  Elucidation of host diversity of the VanD-carrying genomic islands in enterococci and anaerobes.

Authors:  Yusuke Hashimoto; Junzo Hisatsune; Masato Suzuki; Jun Kurushima; Takahiro Nomura; Hidetada Hirakawa; Naoko Kojima; Yuichi Ono; Yutaka Hasegawa; Koichi Tanimoto; Motoyuki Sugai; Haruyoshi Tomita
Journal:  JAC Antimicrob Resist       Date:  2022-01-04

7.  Molecular Characteristics of IS1216 Carrying Multidrug Resistance Gene Cluster in Serotype III/Sequence Type 19 Group B Streptococcus.

Authors:  Yong Zhi; Hyun Jung Ji; Jong Hyun Jung; Eui Baek Byun; Woo Sik Kim; Shun Mei Lin; Sangyong Lim; A-Yeung Jang; Min Joo Choi; Ki Bum Ahn; Jae Hyang Lim; Joon Young Song; Ho Seong Seo
Journal:  mSphere       Date:  2021-07-28       Impact factor: 4.389

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.